NCIMB Secures £1.7m Investment from Scottish Development Entities

NCIMB Limited, a significant player in microbiology services and a custodian of the UK's largest bacterial culture collection, has secured a £1.7 million investment from the Investment Fund for Scotland, managed by Maven Capital Partners and the Scottish National Investment Bank. This financial injection follows an introduction made at a British Business Bank-hosted event in Aberdeen. NCIMB plans to leverage the funding to enhance business development, marketing, and broaden its service offerings, including strain selection and development for specialized client applications. Key stakeholders, including David Milroy of Maven and Edward Green of NCIMB, expressed optimism about scaling NCIMB's operations and tapping into growing market demands. The investment aligns with Maven's interest in contract research organizations and supports the Scottish National Investment Bank's mandate of fostering sustainable economic growth in Scotland. Additionally, Sarah Newbould of the British Business Bank emphasized the significance of NCIMB's work at the interface of science and industry. MBM Commercial LLP provided legal assistance during the transaction.